![]() bayabas, damong maria, ipil-ipil, lagundi, niyog-niyogan, sambong, solasi, tanglad, and ulasimang bato plant parts were supplied to NIRPROMP in varying quantities. This project aimed to: produce medicinal plants raw materials for use of National Integrated Research Program on Medicinal Plants (NIRPROMP) maintain a medicinal plants garden and gene bank conduct regional trials for clinically tested medicinal plants (lagundi, sambong, tsaang gubat) disseminate information on production and utilize medicinal plants. 698 said, there is a need for people to have a healthy lifestyle and be aware of the existence of traditional and alternative medicine which are effective and inexpensive.Production and mass propagation of medicinal plants for primary health careĬollege, Laguna: University of the Philippines Los Banos, 1995. This would make less expensive options in prevention essential. This translates to 19 million poor Filipinos. In September 2021, the National Economic and Development Authority (NEDA) said the Philippines could have a 17.5 percent poverty incidence rate in 2021. The high cost of approved medicines for COVID is likely to bring bigger challenges to Filipinos who are already suffering from income loss. “By treating symptoms at the onset, hospitalizations could be averted and further spread could be prevented by limiting the duration of infectiousness,” it said. The DOST said the heavy expenses could be prevented by early treatment, though. RELATED STORY: Surviving COVID-19: A costly struggle The shortage, however, was not the only problem as Filipinos, especially the poor, had to deal with how expensive these medicines were. The DOST said shortage was inevitable because of heavy demand. When the clinical trials were held, there were only few medicines given “emergency use permits” for patients with severe to critical symptoms of COVID-19. Last October, Guevarra told CNN Philippines that the DOST was planning to register lagundi and tawa-tawa with the FDA as an “added indication” for COVID-19 in three months. ![]() At a Laging Handa briefing, Guevarra said lagundi was proven safe for patients with mild COVID and without comorbidity. The DOST, in June 2020, initiated research on lagundi, which treats cough, and tawa-tawa, which is used to treat symptoms of dengue. In October 2021, Science and Technology Undersecretary Rowena Guevarra said when VCO was mixed with the food of COVID-19 patients, the symptoms eased and there were signs that severe progression of the disease could be prevented. READ: DOST allots P8.4M for virgin coco oil research The investment involved a P4.8 million research study with 74 eligible patients at the Philippine General Hospital and a P3.6 million project led by DOST’s Food and Nutrition Research Institute. In August 2021, the DOST invested P8.4 million to explore the possible benefits of VCO as an “adjunctive therapy” for COVID-19 patients in hospitals to complement primary treatment. ![]() In October 2020, the DOST said VCO, which is readily available in the Philippines, decreases viral load by 60 to 90 percent in mild COVID cases.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |